tiprankstipranks
Beijing Tong Ren Tang Chinese Medicine Co Ltd (HK:3613)
:3613
Hong Kong Market
3613
Beijing Tong Ren Tang Chinese Medicine Co
RESEARCH TOOLSreports
Want to see HK:3613 full AI Analyst Report?

Beijing Tong Ren Tang Chinese Medicine Co (3613) Ratios

2 Followers

Beijing Tong Ren Tang Chinese Medicine Co Ratios

HK:3613's free cash flow for Q4 2025 was HK$0.62. For the 2025 fiscal year, HK:3613's free cash flow was decreased by HK$ and operating cash flow was HK$0.28. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 19.65 19.65 16.85 11.65 8.80
Quick Ratio
 13.16 13.16 10.10 8.59 7.68
Cash Ratio
 10.77 10.77 7.53 3.03 4.76
Solvency Ratio
 1.43 1.43 1.88 1.51 1.48
Operating Cash Flow Ratio
 4.29 4.20 -0.92 1.40 1.31
Short-Term Operating Cash Flow Coverage
 16.95 16.60 -3.06K 2.78K 2.50K
Net Current Asset Value
HK$ 3.77BHK$ 3.77BHK$ 3.65BHK$ 3.43BHK$ 3.20B
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.03 0.03 0.02
Debt-to-Equity Ratio
 0.03 0.03 0.03 0.03 0.03
Debt-to-Capital Ratio
 0.03 0.03 0.03 0.03 0.03
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Financial Leverage Ratio
 1.11 1.11 1.12 1.15 1.17
Debt Service Coverage Ratio
 7.47 7.03 94.89 111.06 158.39
Interest Coverage Ratio
 207.03 83.43 89.02 104.41 174.12
Debt to Market Cap
 <0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 0.15 0.16 0.16 0.16 0.13
Net Debt to EBITDA
 -4.24 -4.24 -2.28 -1.11 -2.08
Profitability Margins
Gross Profit Margin
61.16%61.16%66.10%68.67%66.44%
EBIT Margin
31.45%31.45%39.48%45.49%47.98%
EBITDA Margin
32.74%32.74%44.82%51.12%52.43%
Operating Profit Margin
31.20%31.20%35.80%40.93%46.88%
Pretax Profit Margin
33.35%33.35%39.08%45.10%47.71%
Net Profit Margin
26.25%26.25%31.04%35.44%37.31%
Continuous Operations Profit Margin
27.55%27.55%32.83%38.73%40.02%
Net Income Per EBT
78.71%78.71%79.44%78.57%78.20%
EBT Per EBIT
106.87%106.87%109.16%110.20%101.77%
Return on Assets (ROA)
8.52%8.52%10.97%12.19%15.29%
Return on Equity (ROE)
9.74%9.48%12.28%13.98%17.92%
Return on Capital Employed (ROCE)
10.60%10.60%13.34%15.21%21.32%
Return on Invested Capital (ROIC)
8.66%8.66%11.06%12.88%17.65%
Return on Tangible Assets
8.64%8.64%11.14%12.34%15.51%
Earnings Yield
6.65%5.61%6.81%5.25%6.73%
Efficiency Ratios
Receivables Turnover
 3.62 3.62 3.06 3.61 1.84
Payables Turnover
 9.48 9.48 14.25 2.70 3.78
Inventory Turnover
 0.44 0.44 0.34 0.47 1.24
Fixed Asset Turnover
 3.36 3.36 3.91 3.49 4.27
Asset Turnover
 0.32 0.32 0.35 0.34 0.41
Working Capital Turnover Ratio
 0.40 0.40 0.44 0.45 0.55
Cash Conversion Cycle
 895.31 895.31 1.16K 739.00 397.20
Days of Sales Outstanding
 100.71 100.71 119.13 101.24 198.62
Days of Inventory Outstanding
 833.13 833.13 1.06K 772.98 295.15
Days of Payables Outstanding
 38.52 38.52 25.62 135.22 96.57
Operating Cycle
 933.83 933.83 1.18K 874.22 493.77
Cash Flow Ratios
Operating Cash Flow Per Share
 1.06 1.04 -0.26 0.55 0.65
Free Cash Flow Per Share
 0.99 0.99 -0.31 0.52 0.61
CapEx Per Share
 0.07 0.05 0.05 0.03 0.05
Free Cash Flow to Operating Cash Flow
 0.94 0.95 1.20 0.95 0.93
Dividend Paid and CapEx Coverage Ratio
 2.53 2.60 -0.68 1.55 1.14
Capital Expenditure Coverage Ratio
 15.51 21.08 -5.03 21.08 14.22
Operating Cash Flow Coverage Ratio
 7.01 6.86 -1.76 3.50 5.31
Operating Cash Flow to Sales Ratio
 0.59 0.57 -0.13 0.30 0.32
Free Cash Flow Yield
13.88%11.68%-3.54%4.26%5.31%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 15.05 17.83 14.69 19.05 14.85
Price-to-Sales (P/S) Ratio
 3.95 4.68 4.56 6.75 5.54
Price-to-Book (P/B) Ratio
 1.43 1.69 1.80 2.66 2.66
Price-to-Free Cash Flow (P/FCF) Ratio
 7.21 8.56 -28.22 23.46 18.85
Price-to-Operating Cash Flow Ratio
 6.74 8.16 -33.83 22.34 17.52
Price-to-Earnings Growth (PEG) Ratio
 -0.69 -0.82 -1.91 -1.22 2.71
Price-to-Fair Value
 1.43 1.69 1.80 2.66 2.66
Enterprise Value Multiple
 7.82 10.05 7.89 12.09 8.49
Enterprise Value
 3.88B 4.98B 5.70B 9.43B 7.71B
EV to EBITDA
 7.82 10.05 7.89 12.09 8.49
EV to Sales
 2.56 3.29 3.54 6.18 4.45
EV to Free Cash Flow
 4.67 6.02 -21.89 21.48 15.14
EV to Operating Cash Flow
 4.37 5.74 -26.24 20.46 14.08
Tangible Book Value Per Share
 5.14 5.14 4.99 4.74 4.40
Shareholders’ Equity Per Share
 5.00 5.00 4.87 4.62 4.31
Tax and Other Ratios
Effective Tax Rate
 0.17 0.17 0.16 0.14 0.16
Revenue Per Share
 1.81 1.81 1.93 1.82 2.07
Net Income Per Share
 0.47 0.47 0.60 0.65 0.77
Tax Burden
 0.79 0.79 0.79 0.79 0.78
Interest Burden
 1.06 1.06 0.99 0.99 0.99
Research & Development to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
 0.30 0.26 0.31 0.12 0.09
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.65 2.19 -0.34 0.85 0.66
Currency in HKD